Artigo Acesso aberto Revisado por pares

Consensus Statement on Bone Conduction Devices and Active Middle Ear Implants in Conductive and Mixed Hearing Loss

2022; Lippincott Williams & Wilkins; Volume: 43; Issue: 5 Linguagem: Inglês

10.1097/mao.0000000000003491

ISSN

1537-4505

Autores

H. Maier, Thomas Lenarz, Martijn J.H. Agterberg, Andreas Anagiotos, Susan Arndt, Geoffrey H. Ball, Manohar Bance, Maurizio Barbara, Uwe Baumann, Wolf‐Dieter Baumgartner, Danièle Bernardeschi, Dirk Beutner, Arjan J. Bosman, Robert Briggs, Susan H. Busch, Marco Caversaccio, Markus Dahm, Ernst Dalhoff, Arnaud Deve, Ze, Azadeh Ebrahimi-Madiseh, Bernard Fraysse, H Frenzel, Javier Gavilá, Mohammad Ghoncheh, Bo Håkansson, William Hodgetts, Myrthe K. S. Hol, Julian Holland, Marcus Holmberg, Alexander Huber, Herman A. Jenkins, Roulla Katiri, Kiana Kheirkhah, Assen Koitschev, Martin Kompis, Cris Lanting, Luis Lassaletta, Bob Lerut, R. Leuwer, Thomas Linder, Hubert Lo, Lawrence R. Lustig, Rishi Mandavia, Manuel Manrique, Jorge Humberto Martins, Griet Mertens, Robert Mlynski, Hamidreza Mojallal, Simonetta Monini, Peter Monksfield, Alexander Mu ̈ller, Emmanuel A. M. Mylanus, Hideko Heidi Nakajima, Marcus Neudert, Erwin Offeciers, Flurin Pfiffner, Markus Pietsch, Stefan K. Plontke, Nils Prenzler, Milan Profant, Torsten Rahne, Gunesh P. Rajan, Anna Ratuszniak, Stefan Raufer, Jaydip Ray, Sabine Reinfeldt, Christof Ro ̈o ̈sli, Tove Rosenbom, Rolf Salcher, Matthias Scho, Burkard Schwab, Henryk Skarz, ̇yn ́ski, Piotr Skarz ̇yn ́ski, Hillary Snapp, Georg Mathias Sprinzl, Michael Spearman, Stefan Stenfelt, Christof Stieger, S. Tringali, Éric Truy, James R. Tysome, Paul Van de Heyning, Nicolas Verhaert, Thomas Wesarg, Patrik Westerkull, Barbara Wollenberg, Thomas Zahnert, Andrzej Zarowski, A.F.M. Snik,

Tópico(s)

Hearing Impairment and Communication

Resumo

Nowadays, several options are available to treat patients with conductive or mixed hearing loss. Whenever surgical intervention is not possible or contra-indicated, and amplification by a conventional hearing device (e.g., behind-the-ear device) is not feasible, then implantable hearing devices are an indispensable next option. Implantable bone-conduction devices and middle-ear implants have advantages but also limitations concerning complexity/invasiveness of the surgery, medical complications, and effectiveness. To counsel the patient, the clinician should have a good overview of the options with regard to safety and reliability as well as unequivocal technical performance data. The present consensus document is the outcome of an extensive iterative process including ENT specialists, audiologists, health-policy scientists, and representatives/technicians of the main companies in this field. This document should provide a first framework for procedures and technical characterization to enhance effective communication between these stakeholders, improving health care.

Referência(s)